U.S. Medical School Enrollment Projected to Rise 21 Percent by 2012
Both New and Existing Schools Will Fuel Growth
For Immediate Release News Release
Washington, D.C., May 1, 2008—An annual survey on medical school expansion, released today by the AAMC (Association of American Medical Colleges), indicates that first-year enrollment in U.S. medical schools is estimated to grow 21 percent (3,400 students per year) by 2012 to 19,900 students. Edward Salsberg, director of the association’s Center for Workforce Studies, presented the survey results during his opening remarks to kick off the 2008 AAMC Physician Workforce Research Conference in Crystal City, Va.
According to the survey, more than 86 percent of existing schools have already expanded the number of first-year students or plan to do so within the next five years. In addition, nine new medical schools are under development or discussion, according to the Liaison Committee on Medical Education, which accredits medical education programs leading to an M.D. degree. The AAMC estimates that almost 800 first-year students will attend these new schools in the academic year 2012-13, based on future enrollment figures.
“Ensuring an adequate supply of U.S. physicians is essential for our nation’s health. This projected enrollment increase will help alleviate a future shortage of physicians, although we recognize it is just one part of what must be a comprehensive solution,” said AAMC President and CEO Darrell G. Kirch, M.D. “As more medical school slots become open, this is an excellent time to consider a career in medicine.”
The AAMC Center for Workforce Studies conducted the fourth annual survey of 126 medical school deans in the fall of 2007 to track enrollment and expansion plans over time. A total of 115 schools completed the survey. The information provided by the schools was compared to the baseline academic year of 2002-03, when first-year enrollment totaled 16,448 students.
Survey results indicate that total first-year enrollment in existing U.S. medical schools is projected to increase by 2,635 students (16 percent) by 2012. Public institutions are expected to supply 1,821 of these new enrollment slots (69 percent), and 814 (31 percent) will come from private institutions.
The annual survey of U.S. medical schools is conducted by the AAMC Center for Workforce Studies as part of the association’s ongoing effort to monitor and analyze physician supply and demand.
For a copy of the AAMC 2007 survey on medical school expansion plans, please click on the link.
The Association of American Medical Colleges is a not-for-profit association representing all 129 accredited U.S. and 17 accredited Canadian medical schools; nearly 400 major teaching hospitals and health systems, including 68 Department of Veterans Affairs medical centers; and 94 academic and scientific societies. Through these institutions and organizations, the AAMC represents 109,000 faculty members, 67,000 medical students, and 104,000 resident physicians. Additional information about the AAMC and U.S. medical schools and teaching hospitals is available here.
Â
Applications to U.S. colleges of osteopathic medicine (COMs) have already reached record highs again this year, with many applications yet to be received before the mid-April deadline. The application numbers reflect a six-year period during which several new osteopathic medical schools have been built and thousands of additional potential medical students have applied to enter one of the fastest-growing health care sectors.
Some 11,650 individuals are hoping to fill one of the 4,462 total fall 2008 seats available at the nation’s 25 COMs and their branch campuses, compared with last year’s record-setting 11,459. The growth represents an increase of more than 4 percent over this point in the application cycle last year.
from Inside OME, March 7, 2008
U.S. Med School Seniors Have Most Successful Match Day in 30 years
U.S. medical school seniors celebrated Match Day on Thursday, March 20. More than 94 percent of seniors who applied for residencies this year through the National Resident Matching Program (NRMP) were paired with a program of their choice-the highest percentage in more than three decades. In fact, 84.6 percent of those seniors matched to one of their top three program choices.
The 2008 Match was also the largest ever. Overall, 28,737 applicants vied for one of 22,240 first-year residency positions–the most applicants in history.
A record-high 15, 242 of those applicants were U.S. medical school seniors.
The number of first-year residency positions available through the Match was also the highest in history; 395 additional positions were added this year.
For the full article, please click on the link.Â
from AAMC Stat, March 24, 2008
SBI Health Education’s AIDS Coalition is pleased to invite you to our annual spring HIV awareness event at the UB! This year’s theme will be HIV and the Media: Fight the Stigma and the event will be held on Wednesday April 2nd from 12-3pm in the Student Union Theater.
We will screen the locally-produced short film, “AIDS: Dangerous Silence” and feature a panel discussion with community leaders in media and HIV research:
- Dr. Lance Rintamaki, an assistant professor of communications and health behavior at UB whose HIV research features how stigma affects access to healthcare for HIV-positive individuals
- Chris Voltz, Director of Marketing and Special Projects at AIDS Community Services
- Andrew Galarneau, a Buffalo News reporter who wrote a piece in December 2007 on HIV in Western New York today
Reception afterwards with FREE FOOD and FREE raffle giveaways, including tickets to Darien Lake!
GREAT for pre-health students: As a healthcare professional, how should you talk to with someone living with HIV? How has the media portrayed HIV in the past 25 years, how has it changed, and how SHOULD it be portrayed to address the urgency of the transmission rates without adding further stigma to the disease?
THIS EVENT IS FREE FOR STUDENTS AND FACULTY!
This message is from Rajavi S. Parikh
Organizer, V-Day College Campaign at UB 2008
V-Day is a world campaign to end violence against women and girls. This being the campaign’s 10th year anniversary, we wanted to make sure our V-Day College Campaign at UB 2008 was the biggest it could be to ensure that we increased awareness of this global problem to our campus community. For more information on V-Day, please click on the link.
Below, you will find information about all of the events going on for the campaign, which will take place next week, from March 24th-28. One hundred % of our proceeds will go towards our beneficiaries, Crisis Services, the International Institute of Buffalo, and the Women of New Orleans. Tickets are actually available for all events now at the SBI Ticket office located in 221 Student Union.
Monday, March 24th 2008
Film screening of “Until the Violence Stops”
6:30pm in the Intercultural Diversity Center
Tickets: $3 presale and at the door
Speakers and guided discussion to follow film
Tuesday, March 25th 2008
“These Hands Don’t Hurt” campaign (free event)
Pledge to a life of non-violence
Table in the student union 9am-4pm
Leave your hand print on the windows of the Student Union
(we will have black, white and pink paint with which people can make their hand print and sign their name and a visual representation of the campaign going on that week)
Wednesday, March 26th 2008
The Vagina Monologues
8pm in Goodyear X - South Campus
Tickets $8 presale, $10 at the door
Thursday, March 27th 2008
The Vagina Monologues
8pm in Woldman Theatre (Norton 112) - North Campus
Tickets $8 presale, $10 at the door
Friday, March 28th 2008
A Memory, A Monologue, A Rant and A Prayer
8pm in Goodyear X - South Campus
Tickets $8 presale, $10 at the door
Please feel free to share this information with anyone else who may want to support the cause.
Until the violence stops,
Rajavi S. Parikh
Organizer, V-Day College Campaign at UB 2008
Please click on the link for USA Today to read this article.
Preliminary accreditation has been granted to the Florida International University College of Medicine. They will welcome their inaugural MD class in August 2009, and will be accepting applications through AMCAS in June 2008. The program emphasis is community-based, patient-centered learning with the development of an understanding of personal, cultural and social factors affecting health care. Students will develop competencies in a full range of medical specialties. Information regarding this new medical school can be found on their website or in the next Medical School Admission Requirements (MSAR).
In order to apply to the FIU College of Medicine you must be a US Citizen or Permanent Resident Alien. Although preference will be given to residents of the State of Florida, well qualified residents of other states are encouraged to apply. Verification including driver’s license, vehicle registration and voter registration will be required.
You can click on the following click to see MCAT and GPA data for students admitted (by state) to US MD schools for 2007. Please weigh this carefully as you consider applying for fall 2009.
You can also see comprehensive data on applicants, matriculants and graduates to US MD schools here. here
ANTI-CANCER DRUG: An anti-cancer drug developed by Kinex Pharmaceuticals of Buffalo and a UB faculty researcher has begun clinical testing with patients with advanced cancer who have not responded to other therapies. Read more about this anti-cancer drug discovery.
FAST-FOOD DANGER: Eating a typical fast-food meal of a burger, fries, large beverage and apple pie puts more stress on the lining of blood vessels, raising heart-attack risk, in the obese than in individuals of normal weight, according to UB researchers. Learn more about this fast-food danger.
FOCUS ON WORMS: A professor in the College of Arts and Sciences is focusing on microscopic worms to learn more about conditions such as Parkinson’s disease and Alzheimer’s disease related to aging in humans. Read more about these microscopic worms.
INEXPENSIVE TESTING: UB medical researchers have shown that a simple and inexpensive technique employed currently to assess glaucoma could be used instead of expensive magnetic resonance imaging to monitor the progression of multiple sclerosis and to assess the effectiveness of new and current MS treatments. Learn more about this testing
ANTI-CANCER DRUG: An anti-cancer drug developed by Kinex Pharmaceuticals of Buffalo and a UB faculty researcher has begun clinical testing with patients with advanced cancer who have not responded to other therapies.
Read more about this anti-cancer drug discovery
